Global biotechnology company and specialists in microbial solutions Novozymes has struck a deal with German-based researchers Organobalance. Although Novozymes is not revealing financial details of the acquisition, it says the deal will complement the company’s existing platform with applications across industries.
Organobalance GmbH specializes in microbial screening, assay technology and developing natural microbial solutions for food industry partners. It owns a large collection of microbial strains, some dating back to the 1920s, and has expertise in screening and metabolic engineering for new product developments for food applications.
The company works on improving shelf life, protection from microbial contamination, infections, pathogenic bacteria, clean label solutions by replacing undesirable ingredients and using natural alternatives as well as the economic production of these natural ingredients for improved texture, flavor, color and stability.
“The experience of Organobalance’s founding scientists, and the company’s know-how, immediately strengthen Novozymes’ existing capabilities within microbial technologies,” says Sebastian Soderberg, vice president for new business development, incubation & acquisitions at Novozymes. “Organobalance will advance our understanding to develop new, sustainable solutions across industries, and provide us with additional commercial opportunities.”
Organobalance will be integrated into Novozymes’ global organization but will continue to be based in Germany so as to benefit from the established biotechnology capabilities of the country’s capital region and the company’s strong ties to German academia, innovation environments, and markets.
“Organobalance and Novozymes possess similar ambitions and company cultures,” adds Soderberg.
Source: Food Ingredients First
Neste Corporation’s Board of Directors has appointed Heikki Malinen, M.Sc. (Econ.), MBA (Harvard) as the President and CEO of Neste as of 2 November 2024, at the latest. Malinen joins Neste from Outokumpu Corporation where he has held the position of President and CEO since 2020.
Petrochemicals company Sasol has announced that CFO and executive director Hanré Rossouw will step down from his position, effective October 31. Sasol has started the process to appoint a successor. Rossouw will still oversee the publication of Sasol’s reports for the financial year ending June 30, to allow for a structured handover period.
Chemours announced its CFO Jonathan Lock has resigned from all positions within the company, according to an SEC 8-K filing on April 23. The resignation comes in the aftermath of the company announcing that Lock, former CEO Mark Newman, and principal accounting officer Camela Wisel, had been placed on administrative leave.
